Todd Fox
University of Virginia
H-index: 39
North America-United States
Top articles of Todd Fox
Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes
Blood Advances
2024/3/12
Pronecroptotic Therapy Using Ceramide Nanoliposomes Is Effective for Triple-Negative Breast Cancer Cells
Cells
2024/2/26
A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
Cancer chemotherapy and pharmacology
2024/1
Preclinical development of a novel Romidepsin nanoparticle for the treatment of T-Cell lymphoid malignancies
Cancer Research
2024/3/22
Acid ceramidase inhibition enhances venetoclax sensitivity in preclinical models of acute myeloid leukemia
Cancer Research
2024/3/22
Use of hypomethylating agents to reprogram the epigenome in large granular lymphocyte leukemia
Cancer Research
2024/3/22
Ipsita Pal
H-Index: 15
Todd Fox
H-Index: 25
The casein kinase 2/IKZF1 axis attenuates ceramide accumulation through up-regulation of acid ceramidase: Implications for use of CK2 inhibitors in high-risk pediatric B-cell …
Cancer Research
2024/3/22
Chemical fabrication and characterization of a novel nanoparticle of the histone deacetylase (HDACi) romidepsin
Cancer Research
2024/3/22
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid Leukemia
Cancers
2023/12/15
Solid tumor treatment via augmentation of bioactive C6 ceramide levels with thermally ablative focused ultrasound
Drug Delivery and Translational Research
2023/12
Todd Fox
H-Index: 25
Tricarboxylic acid (TCA) cycle, sphingolipid, and phosphatidylcholine metabolism are dysregulated in T. gondii infection-induced cachexia
Heliyon
2023/7/1
Synthesis and Preclinical Development of a Promising Novel Romidepsin Nanoparticle for the Treatment of Peripheral T‐Cell Lymphoma (PTCL)
Hematological Oncology
2023/6
Identifying the mechanistic differences between hypomethylating agents for the treatment of peripheral T cell lymphoma
Hematological Oncology
2023/6
Simultaneous Inhibition of Ceramide Hydrolysis and Glycosylation Synergizes to Corrupt Mitochondrial Respiration and Signal Caspase Driven Cell Death in Drug-Resistant Acute …
Cancers
2023/3/21
Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma
Cells
2023/2/11
Ceramide analog saclac modulates sphingolipid levels and mcl-1 splicing to induce apoptosis in acute myeloid leukemia
2022/12/8
Ceramide ratios as predictive and therapeutic biomarkers for leukemias
2022/11/17
Nanoliposomal C6-Ceramide Exhibits Synergistic Anti-Cancer Activity with a Small Molecule Agonist of PP2A in Chronic Lymphocytic Leukemia
Blood
2022/11/15
Compositions and methods for preventing and/or reducing weight gain and associated conditions
2021/8/12
AML-080 Superior Anti-Leukemic Effects of Combined Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia
Clinical Lymphoma Myeloma and Leukemia
2022/10/1
Jeremy Shaw
H-Index: 9
Todd Fox
H-Index: 25
Co-Authors
